![]()
Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | (-)-epigallocatechin 3-gallate | multiple interactions | ISO | RGD:1316654 | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of DNAJB5 mRNA | CTD | PMID:22079256 | 1,2-dimethylhydrazine | increases expression | ISO | RGD:1620860 | 6480464 | 1, 2-Dimethylhydrazine results in increased expression of DNAJB5 mRNA | CTD | PMID:22206623 | 15-acetyldeoxynivalenol | increases expression | ISO | RGD:1316654 | 6480464 | 15-acetyldeoxynivalenol results in increased expression of DNAJB5 mRNA | CTD | PMID:23792671 | 17beta-estradiol | multiple interactions | ISO | RGD:1316654 | 6480464 | [Estradiol co-treated with TGFB1 protein] results in increased expression of DNAJB5 mRNA | CTD | PMID:30165855 | 17beta-hydroxy-5alpha-androstan-3-one | increases expression | ISO | RGD:1316654 | 6480464 | Dihydrotestosterone results in increased expression of DNAJB5 mRNA | CTD | PMID:29581250 | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:1316654 | 6480464 | Cycloheximide inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of DNAJB5 mRNA] | CTD | PMID:11007951 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of DNAJB5 mRNA | CTD | PMID:32109520 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:1620860 | 6480464 | Tetrachlorodibenzodioxin affects the expression of DNAJB5 mRNA | CTD | PMID:21570461, PMID:24680724 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:1316654 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of DNAJB5 mRNA | CTD | PMID:11007951 | 2-hydroxypropanoic acid | increases expression | ISO | RGD:1316654 | 6480464 | Lactic Acid results in increased expression of DNAJB5 mRNA | CTD | PMID:30851411 | 3,4-methylenedioxymethamphetamine | increases expression | EXP | | 6480464 | N-Methyl-3, 4-methylenedioxyamphetamine results in increased expression of DNAJB5 mRNA | CTD | PMID:30071829 | 3-isobutyl-1-methyl-7H-xanthine | multiple interactions | ISO | RGD:1316654 | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of DNAJB5 mRNA | CTD | PMID:28628672 | 4,4'-sulfonyldiphenol | increases methylation | ISO | RGD:1620860 | 6480464 | bis(4-hydroxyphenyl)sulfone results in increased methylation of DNAJB5 promoter | CTD | PMID:33297965 | 4,4'-sulfonyldiphenol | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with bisphenol F co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of DNAJB5 mRNA | CTD | PMID:36041667 | acrylamide | affects expression | EXP | | 6480464 | Acrylamide affects the expression of DNAJB5 mRNA | CTD | PMID:28959563 | all-trans-retinoic acid | increases expression | ISO | RGD:1316654 | 6480464 | Tretinoin results in increased expression of DNAJB5 mRNA | CTD | PMID:23724009 | all-trans-retinoic acid | decreases expression | ISO | RGD:1316654 | 6480464 | Tretinoin results in decreased expression of DNAJB5 mRNA | CTD | PMID:33167477 | bisphenol A | affects expression | EXP | | 6480464 | bisphenol A affects the expression of DNAJB5 mRNA | CTD | PMID:25181051 | bisphenol A | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with bisphenol F co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of DNAJB5 mRNA | CTD | PMID:36041667 | bisphenol A | multiple interactions | ISO | RGD:1316654 | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of DNAJB5 mRNA | CTD | PMID:28628672 | bisphenol F | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with bisphenol F co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of DNAJB5 mRNA | CTD | PMID:36041667 | C60 fullerene | affects expression | EXP | | 6480464 | fullerene C60 affects the expression of DNAJB5 mRNA | CTD | PMID:19167457 | cadmium dichloride | increases methylation | EXP | | 6480464 | Cadmium Chloride results in increased methylation of DNAJB5 promoter | CTD | PMID:22457795 | choline | multiple interactions | ISO | RGD:1620860 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of DNAJB5 gene | CTD | PMID:20938992 | chromium(6+) | decreases expression | ISO | RGD:1316654 | 6480464 | chromium hexavalent ion results in decreased expression of DNAJB5 mRNA | CTD | PMID:30690063 | chrysene | increases expression | ISO | RGD:1620860 | 6480464 | chrysene results in increased expression of DNAJB5 mRNA | CTD | PMID:26377693 | ciglitazone | increases expression | EXP | | 6480464 | ciglitazone results in increased expression of DNAJB5 mRNA | CTD | PMID:22193206 | cisplatin | increases expression | ISO | RGD:1620860 | 6480464 | Cisplatin results in increased expression of DNAJB5 mRNA | CTD | PMID:25270620 | cisplatin | increases expression | ISO | RGD:1316654 | 6480464 | Cisplatin results in increased expression of DNAJB5 mRNA | CTD | PMID:27392435 | cycloheximide | multiple interactions | ISO | RGD:1316654 | 6480464 | Cycloheximide inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of DNAJB5 mRNA] | CTD | PMID:11007951 | dexamethasone | multiple interactions | ISO | RGD:1316654 | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of DNAJB5 mRNA | CTD | PMID:28628672 | dichloroacetic acid | decreases expression | ISO | RGD:1620860 | 6480464 | Dichloroacetic Acid results in decreased expression of DNAJB5 mRNA | CTD | PMID:28962523 | dimethyl sulfoxide | increases expression | EXP | | 6480464 | Dimethyl Sulfoxide results in increased expression of DNAJB5 mRNA | CTD | PMID:22193206 | doxorubicin | decreases expression | ISO | RGD:1316654 | 6480464 | Doxorubicin results in decreased expression of DNAJB5 mRNA | CTD | PMID:29803840 | doxorubicin | decreases expression | EXP | | 6480464 | Doxorubicin results in decreased expression of DNAJB5 mRNA | CTD | PMID:30261314 | ethanol | decreases expression | ISO | RGD:1620860 | 6480464 | Ethanol results in decreased expression of DNAJB5 mRNA | CTD | PMID:29018328 | ethyl methanesulfonate | increases expression | ISO | RGD:1316654 | 6480464 | Ethyl Methanesulfonate results in increased expression of DNAJB5 mRNA | CTD | PMID:23649840 | folic acid | multiple interactions | ISO | RGD:1620860 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of DNAJB5 gene | CTD | PMID:20938992 | furan | decreases expression | EXP | | 6480464 | furan results in decreased expression of DNAJB5 mRNA | CTD | PMID:25539665 | genistein | increases expression | ISO | RGD:1620860 | 6480464 | Genistein results in increased expression of DNAJB5 mRNA | CTD | PMID:32186404 | gentamycin | decreases expression | EXP | | 6480464 | Gentamicins results in decreased expression of DNAJB5 mRNA | CTD | PMID:22061828 | gentamycin | increases expression | EXP | | 6480464 | Gentamicins results in increased expression of DNAJB5 mRNA | CTD | PMID:33387578 | hydrogen cyanide | decreases expression | ISO | RGD:1620860 | 6480464 | Hydrogen Cyanide results in decreased expression of DNAJB5 mRNA | CTD | PMID:33914522 | indometacin | multiple interactions | ISO | RGD:1316654 | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of DNAJB5 mRNA | CTD | PMID:28628672 | L-methionine | multiple interactions | ISO | RGD:1620860 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of DNAJB5 gene | CTD | PMID:20938992 | methamphetamine | multiple interactions | EXP | | 6480464 | SCH 23390 inhibits the reaction [Methamphetamine results in increased expression of DNAJB5 mRNA] | CTD | PMID:19564919 | methamphetamine | increases expression | EXP | | 6480464 | Methamphetamine results in increased expression of DNAJB5 mRNA | CTD | PMID:19564919 | methotrexate | decreases expression | ISO | RGD:1316654 | 6480464 | Methotrexate results in decreased expression of DNAJB5 mRNA | CTD | PMID:17400583 | methotrexate | increases expression | ISO | RGD:1316654 | 6480464 | Methotrexate results in increased expression of DNAJB5 mRNA | CTD | PMID:24449571 | methylmercury chloride | increases expression | ISO | RGD:1316654 | 6480464 | methylmercuric chloride results in increased expression of DNAJB5 mRNA | CTD | PMID:28001369 | methylseleninic acid | increases expression | ISO | RGD:1316654 | 6480464 | methylselenic acid results in increased expression of DNAJB5 mRNA | CTD | PMID:18548127 | mitomycin C | increases expression | ISO | RGD:1620860 | 6480464 | Mitomycin results in increased expression of DNAJB5 mRNA | CTD | PMID:25270620 | N-methyl-N-nitrosourea | increases expression | ISO | RGD:1620860 | 6480464 | Methylnitrosourea results in increased expression of DNAJB5 mRNA | CTD | PMID:25270620 | nevirapine | increases expression | EXP | | 6480464 | Nevirapine metabolite results in increased expression of DNAJB5 mRNA | CTD | PMID:23947594 | ozone | multiple interactions | ISO | RGD:1620860 | 6480464 | [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of DNAJB5 mRNA | CTD | PMID:34911549 | paracetamol | increases expression | ISO | RGD:1316654 | 6480464 | Acetaminophen results in increased expression of DNAJB5 mRNA | CTD | PMID:22230336 | paracetamol | increases expression | EXP | | 6480464 | Acetaminophen results in increased expression of DNAJB5 mRNA | CTD | PMID:33387578 | perfluorononanoic acid | decreases expression | ISO | RGD:1316654 | 6480464 | perfluoro-n-nonanoic acid results in decreased expression of DNAJB5 mRNA | CTD | PMID:32588087 | phenobarbital | affects expression | ISO | RGD:1316654 | 6480464 | Phenobarbital affects the expression of DNAJB5 mRNA | CTD | PMID:19159669 | phenylephrine | increases expression | EXP | | 6480464 | Phenylephrine results in increased expression of DNAJB5 mRNA | CTD | PMID:18158353 | pirinixic acid | multiple interactions | ISO | RGD:1620860 | 6480464 | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of DNAJB5 mRNA, PPARA protein affects the reaction [pirinixic acid results in decreased expression of DNAJB5 mRNA] | CTD | PMID:19710929, PMID:21318169 | pirinixic acid | decreases expression | ISO | RGD:1620860 | 6480464 | pirinixic acid results in decreased expression of DNAJB5 mRNA | CTD | PMID:21318169 | potassium chromate | multiple interactions | ISO | RGD:1316654 | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of DNAJB5 mRNA | CTD | PMID:22079256 | potassium chromate | decreases expression | ISO | RGD:1316654 | 6480464 | potassium chromate(VI) results in decreased expression of DNAJB5 mRNA | CTD | PMID:22079256, PMID:22714537 | potassium cyanide | increases expression | ISO | RGD:1620860 | 6480464 | Potassium Cyanide results in increased expression of DNAJB5 mRNA | CTD | PMID:33914522 | rac-lactic acid | increases expression | ISO | RGD:1316654 | 6480464 | Lactic Acid results in increased expression of DNAJB5 mRNA | CTD | PMID:30851411 | rotenone | affects expression | ISO | RGD:1620860 | 6480464 | Rotenone affects the expression of DNAJB5 mRNA | CTD | PMID:23186747 | SCH 23390 | multiple interactions | EXP | | 6480464 | SCH 23390 inhibits the reaction [Methamphetamine results in increased expression of DNAJB5 mRNA] | CTD | PMID:19564919 | silicon dioxide | decreases expression | ISO | RGD:1316654 | 6480464 | Silicon Dioxide analog results in decreased expression of DNAJB5 mRNA | CTD | PMID:25895662 | sodium arsenate | decreases expression | ISO | RGD:1620860 | 6480464 | sodium arsenate results in decreased expression of DNAJB5 mRNA | CTD | PMID:21795629 | sodium arsenate | increases expression | ISO | RGD:1620860 | 6480464 | sodium arsenate results in increased expression of DNAJB5 mRNA | CTD | PMID:21795629 | sodium arsenite | increases expression | ISO | RGD:1316654 | 6480464 | sodium arsenite results in increased expression of DNAJB5 mRNA | CTD | PMID:21457566 | sunitinib | decreases expression | ISO | RGD:1316654 | 6480464 | Sunitinib results in decreased expression of DNAJB5 mRNA | CTD | PMID:31533062 | thioacetamide | decreases expression | EXP | | 6480464 | Thioacetamide results in decreased expression of DNAJB5 mRNA | CTD | PMID:34492290 | titanium dioxide | increases expression | ISO | RGD:1620860 | 6480464 | titanium dioxide results in increased expression of DNAJB5 mRNA | CTD | PMID:29264374 | urethane | decreases expression | ISO | RGD:1316654 | 6480464 | Urethane results in decreased expression of DNAJB5 mRNA | CTD | PMID:28818685 | valproic acid | increases expression | ISO | RGD:1316654 | 6480464 | Valproic Acid results in increased expression of DNAJB5 mRNA | CTD | PMID:19101580 | |